Intuitive Intelligence
MARCH 26, 2024
In life, our purpose often hides in our experiences. Our journey to discovering our purpose can feel like a tough ride through the highs and lows of life. But within these ups and downs lies the true discovery of who we are and what drives us. Trials and Tribulations Reflecting on my own journey for purpose, I realize it’s a journey rooted in my upbringing and the trials I faced.
Noreta Family Medicine
MARCH 20, 2024
What is primary care? Part 1 How do I choose a primary care physician? Choosing a doctor can be difficult! After all, you will be going to this doctor to discuss almost all of your health needs and concerns (at least initially!). You need to be able to trust your doctor and build a relationship with them. Here are some questions to consider along with a few tips for finding a primary care doctor: 1) How easy is it to get in touch with your doctor and their office?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Logansport Memorial Hospital
MARCH 4, 2024
Logansport Memorial Hospital is pleased to announce the opening of a new pain management center on April 1, 2024. The Logansport Memorial Pain Management Center will be located at 1201 Michigan Avenue, Suite 70, Logansport, IN 46947. Chronic pain can affect all areas of our lives, including our relationships, sleep, and mental health, and it may even lead to a lower quality of life.
Myriad Genetics
MARCH 13, 2024
Many of us have seen stories in the news about American families on diagnostic odysseys for their children with rare diseases. Recently, the Today Show highlighted Courtney (she asked that only first names be used), who visited 17 different doctors over three years to help diagnose her young son Alex, who she was watching suffer and decline before her eyes.
Boulder Medical Center
MARCH 3, 2024
Board-certified gastroenterologist Christie Blanton, MD, explains colon cancer screenings, from non-invasive stool tests to colonoscopies. The post Four Types of Colon Cancer Screenings appeared first on Boulder Medical Center.
GeriPal
MARCH 14, 2024
Summary Transcript Summary Almost a decade ago, our hospice and palliative care team decided to do a “Thickened Liquid Challenge.” This simple challenge was focused on putting ourselves in the shoes of our patients with dysphagia who are prescribed thickened liquids. The rules of the challenge were simple: fluids must be thickened to “honey consistency” using a beverage thickener for a 12-hour contiguous period.
The Clinical Problem Solvers
MARCH 19, 2024
[link] In this clinical reasoning Rafael Medina Subspecialty episode, Dr. Mark Heslin presents a case to Dr. Tony Breu of a man presenting with facial swelling. Session facilitator: Youssef Saklawi The goal of this series is to expand access to subspecialty, primary care, and internal medicine-adjacent specialty education to learners around the world.
Primary Care Digest brings together the best content for architecture professionals from the widest variety of industry thought leaders.
Logansport Memorial Hospital
MARCH 20, 2024
At Logansport Memorial Hospital, we know how an unexpected injury or illness can impact your daily routine and quality of life. Ending up in the hospital can be scary and worrisome for patients and their families, and Eduardo Sanchez Castillo’s experience was no different. Luckily, he quickly learned that he was in good hands with Jennay Jones, NP and the rest of our skilled staff in the Wound Care Center.
Oasis Family Medicine
MARCH 26, 2024
I recently had the privilege of joining Dr. Joy Kong on her podcast, Episode 65: Introducing EBOO. During our conversation, I discussed how EBOO (Extracorporeal Blood Oxygenation & Ozonation) has become quite a popular treatment in the holistic health and biohacking community. Based on my extensive experience, research, and studies conducted with EBOO therapy, we explored what this therapy can do for the body, the difference between EBOO and traditional ozone therapy (MAH - Major Autohemathe
Adventures of a Sick Doctor
MARCH 8, 2024
I haven’t written anything here for a long time, and it’s hard to say what is the real prompt for me to break my silence today, but here goes. When I was busy having various cancer adventures, I always felt better after I spewed out all my thoughts and worries onto the keyboard. It’s funny how much easier it was to be open about my fears and concerns about cancer, than it is to talk about anything in the ordinary humdrumness of life.
GeriPal
MARCH 4, 2024
The #HPMParty is returning to Phoenix during the 2024 AAHPM/HPNA meeting. We will be doing our traditional Pub Crawl, this time in the Roosevelt Row Arts District just north of the convention center. We’ll start our annual tour of local establishments at Luckys Indoor/Outdoor (817 N. 2nd Street) at 8pm on Thursday, March 21st (we moved it up from our traditional 9pm start to give a little extra time for those coming from the east coast.
The Clinical Problem Solvers
MARCH 7, 2024
[link] Episode title: Episode 323: Neurology VMR – Visual hallucinations Episode description: We continue our campaign to #EndNeurophobia, with the help of Dr. Aaron Berkowitz. This time, Valeria presents a case of visual hallucinations to Greg and Umbish. Neurology DDx Schema Valeria Roldan @valeroldan23 Valeria Roldan was born and raised in Lima, Peru.
FDA Law Blog
MARCH 3, 2024
By Steven J. Gonzalez & JP Ellison — The most recent version of the BIOSECURE Act (the “Act”) was introduced in the U.S. House of Representatives ( H.B. 7085 ) and Senate ( S.B. 3558 ) on January 25, 2024. This proposed legislation should be of interest to any biotechnology companies that want to do business with the federal government in the future.
Logansport Memorial Hospital
MARCH 7, 2024
When it comes to wound care, stress can play a major factor in your healing journey. For many, being in a clinical setting can spike stress and anxiety. It’s important to be able to trust your caregivers, and here at Logansport Memorial, we go above and beyond to develop relationships with our patients and provide personalized, high-quality care for our community.
Evergreen Family Medicine
MARCH 29, 2024
It’s called “the green journal.” When I was in medical school in the 1970’s, it was the source most frequently quoted by faculty at OHSU. The American Journal of Medicine is the official journal of the Alliance for Academic Internal Medicine, a prestigious group of internal medicine department chairs at the top 125 medical schools across the U.S. In addition to its academic rigor, one of its primary stated aims is to enhance knowledge and improve effectiveness of public health interventions.
CDOCS
MARCH 4, 2024
<p>According to the Dental Assisting National Board, dental assistant job satisfaction has declined every year since 2016, and currently only 50% feel valued by their employer. Within the last year, feeling under appreciated is now the second highest reason dental assistants are leaving the dental field.</p> <p>Even with the boosted team member benefits and increased hourly compensation, staff exodus and rising dissatisfaction are near the top of practice owners&rsquo
PEMBlog
MARCH 21, 2024
Be sure to check out our previous posts on: BRONCHIOLITIS , EPIGLOTTITIS , and PNEUMONIA The Problem: Free open access medical education (aka FOAM) is great in that it allows for asynchronous, focused learning. But there are some challenges when it comes to the utilization of FOAM: – Decentralization of FOAM resources – Concerns about the quality of information being presented The Solution: The Systematic Online Academic Resource, or SOAR, review was created in an effort to address some of these
Oasis Family Medicine
MARCH 26, 2024
In this podcast hosted by Dr. Katie Carter, I had an awesome opportunity to collaborate with Dr. Mike Belkowski, Founder of BioLight, where we had an informative discussion on methylene blue and leucomethylene blue, as well as red light therapy. I did this podcast because Dr. Mike's products are best in class when it comes to these products. Please watch the podcast and then check out the BioLight products in our Store.
FDA Law Blog
MARCH 7, 2024
By Frank J. Sasinowski — In 2009 — 15 years ago — the National Organization for Rare Disorders (NORD) announced the first U.S. recognition of Rare Disease Day. NORD’s announcement followed in the footsteps of European rare disease patient organization, Eurodis , who had celebrated the first Rare Disease Day the year before. Time flies when your goal is to support the thirty million people that suffer from rare diseases.
Logansport Memorial Hospital
MARCH 26, 2024
The total solar eclipse on April 8, 2024, will cast much of Indiana in a state of total darkness. Excitement is building across the state, and the state is expecting to see over anywhere from 145,000 to 581,000 out-of-state visitors traveling to view this solar event. We want to ensure that you’re prepared to safely enjoy the eclipse. What is a solar eclipse?
The Clinical Problem Solvers
MARCH 13, 2024
[link] Sharmin , Jack, and Youssef discuss their approach to joint pain as they reason through a case presented by Maddy. Monoarticular Arthritis Framework To join us live on Virtual Morning Report (VMR), sign up HERE.
Maine Academy of Family Physicians
MARCH 1, 2024
Time is of the essence - SPEAK OUT TODAY! Please take a minute to contact your state legislators and urge them to vote YES on LD 1215, "An Act to End the Sale of Flavored Tobacco Products". There is a vote coming up in the legislature this week or next. We are a few votes short of passage in the House. Those legislators who are wavering on the vote need to hear YOUR voice.
PEMBlog
MARCH 20, 2024
Be sure to check out our previous posts on: BRONCHIOLITIS and EPIGLOTTITIS The Problem: Free open access medical education (aka FOAM) is great in that it allows for asynchronous, focused learning. But there are some challenges when it comes to the utilization of FOAM: – Decentralization of FOAM resources – Concerns about the quality of information being presented The Solution: The Systematic Online Academic Resource, or SOAR, review was created in an effort to address some of these limitations.
Vida Family Medicine
MARCH 28, 2024
Over the last few years, there has been near non-stop media and social media coverage of the "new weight loss drugs," GLP-1 receptor agonists such as semaglutide (Ozempic and Wegovy) and GLP-1 and GIP receptor agonist tirzepatide (Mounjaro and Zepbound). In reality, GLP-1 receptor agonists have been available for many years for the treatment of type 2 diabetes (Victoza, Trulicity, etc) and for weight loss (Saxenda), while tirzepatide is new in the last few years.
FDA Law Blog
MARCH 31, 2024
By Ana Loloei & Jeffrey N. Gibbs — On March 21, 2024, the House Energy and Commerce held a subcommittee hearing titled “Evaluating Approaches to Diagnostic Test Regulation and the Impact of the FDA’s Proposed Rule.” House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Subcommittee Chair Brett Guthrie (R-KY), in announcing the hearing, made their views clear: “FDA has proposed a rule that relies upon dubious and misguided legal, economic, and public health arguments and
Myriad Genetics
MARCH 19, 2024
Colorectal cancer, once considered a disease of the elderly, is now increasingly affecting younger individuals. A study by the American Cancer Society and published in CA: A Cancer Journal for Clinicians found that half of all new colorectal cancer diagnoses are in people 66 and younger. Further, according to the Journal of the American Medical Association , colorectal cancer is estimated to become the leading cause of cancer-related deaths among younger adults (ages 20 to 49) in the United Stat
The Clinical Problem Solvers
MARCH 27, 2024
[link] Episode description Reza and Rabih discuss a case of a patient with whole body pain Student discount [link] IMG discount Use coupon code RLRIMG at check out [link]
GeriPal
MARCH 28, 2024
Summary Transcript Summary One marker of the distance we’ve traveled in palliative care is the blossoming evidence base for the field. Ten years ago we would have been hard pressed to find 3 clinical trial abstracts submitted to the annual meeting, much less high quality randomized trials with robust measures, sample sizes, and analytics plans. Well, as a kick off to this year’s first in-person State of the Science plenary, held in conjunction with the closing Saturday session of the AAHPM/HPNA
PEMBlog
MARCH 19, 2024
Be sure to check out our previous post on: BRONCHIOLITIS The Problem: Free open access medical education (aka FOAM) is great in that it allows for asynchronous, focused learning. But there are some challenges when it comes to the utilization of FOAM: – Decentralization of FOAM resources – Concerns about the quality of information being presented The Solution: The Systematic Online Academic Resource, or SOAR, review was created in an effort to address some of these limitations.
FDA Law Blog
MARCH 21, 2024
By John W.M. Claud — The American Conference Institute’s 11th Annual Legal, Regulatory, and Compliance Forum on Cosmetics & Personal Care Products took place this week in New York, and featured a full house of folks talking about the Modernization of Cosmetics Regulation Act (MoCRA) , the legal considerations around making environmental, sustainable, and green (ESG) claims, and the impact of state laws.
FDA Law Blog
MARCH 11, 2024
By Adrienne R. Lenz, Principal Medical Device Regulation Expert & Allyson B. Mullen — On February 20, 2024, FDA issued a letter to the medical device industry ( link ) warning medical device firms of recent FDA concerns related to fraudulent and unreliable laboratory testing data in premarket submissions. Unfortunately, the letter provides little new information to guide industry conduct.
FDA Law Blog
MARCH 10, 2024
Last August the Food and Drug Administration (“FDA”)/Health and Human Services (“HHS”) recommended that the Drug Enforcement Administration (“DEA”) reschedule cannabis from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. By doing so, FDA/HHS believe that cannabis no longer meets schedule I criteria but does not meet schedule II criteria either.
FDA Law Blog
MARCH 7, 2024
By Véronique Li, Senior Medical Device Regulation Expert & Jeffrey N. Gibbs — Our last post on small business certification requests described how small medical device manufacturers, defined as those with gross receipts of less than $100 million in gross receipts and sales for the most recent tax year, are eligible for a reduced fee on those medical device submissions that require a user fee.
FDA Law Blog
MARCH 5, 2024
By Faraz Siddiqui — Last Friday, the Delaware District Court rejected AstraZeneca’s lawsuit against the Medicare Drug Price Negotiation Program enacted under the Inflation Reduction Act (IRA) and CMS’s guidance implementing it. AstraZeneca, whose drug Farxiga was selected last September for negotiations for price applicability year 2026, claimed that the IRA violated AstraZeneca’s Fifth Amendment right to due process because it deprived the company of its investment-backed patent rights and comm
FDA Law Blog
MARCH 3, 2024
By Jeffrey N. Gibbs & Allyson B. Mullen — FDA’s proposed rule to regulate laboratory developed tests (LDTs) as devices took one more step towards being finalized – and to a likely judicial showdown. On March 1, the Office of Management and Budget (OMB) received the draft final LDT rule for review ( here ). The LDT rule has moved forward with astonishing speed, advancing from the release of the proposed rule on October 3, 2023 to OMB in less than five months.
FDA Law Blog
MARCH 29, 2024
By John W.M. Claud & Kalie E. Richardson — While Covid is in the rear view for most of us, FDA has had a tough time shaking off the effects of the pandemic on its inspection output. Inspections went down—way down—during the pandemic. In March 2020 , FDA temporarily postponed all foreign and domestic and routine surveillance facility inspections.
FDA Law Blog
MARCH 26, 2024
By Sara W. Koblitz — The FTC appears to be on a mission to cleanse the Orange Book of patents it deems improperly listed. For the second time in recent years, the FTC has filed an Amicus Brief explaining exactly which patents should not be in the Orange Book. Last time, back in 2022 , the FTC took on REMS patents, explaining in litigation between Jazz and Avadel that the listing of REMS patents in the Orange Book is anticompetitive; this time, the FTC is going after device patents.
Expert insights. Personalized for you.
130 
Let's personalize your content